Product Information
ROPINIROLE HCL 0.25 MG TABLET is a generic product labeled by Solco Healthcare US LLC, priced at $0.0456 per EA under NDC 43547026850. Its NADAC has been published 659 times since Jan 8, 2014.
FDA first approved this application on May 5, 2008. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.25 mg/1
Manufacturer
Solco Healthcare US LLCNDC
43547026850
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ROPINIROLE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA078110FDA Approved
5/5/2008
TE Code
AB
On Market Since
9/20/2011
Pharmacological Classes
Price Statistics
The NADAC for ROPINIROLE HCL 0.25 MG TABLET has been published 659 times since Jan 8, 2014, and over the history we have for it it has declined 63.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0456 per EA |
|---|---|
| All-time high | $0.1260 (Mar 12, 2014) |
| All-time low | $0.0347 (Nov 20, 2024) |
| 52-week high | $0.0476 |
| 52-week low | $0.0453 |
| Median price | $0.0648 |
| Average price | $0.0712 |
| Largest weekly change | -28.4% (Nov 20, 2024) |
| Weeks tracked | 659 |
| Tracking since | Jan 8, 2014 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ROPINIROLE HCL 0.25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ROPINIROLE HCL 0.25 MG TABLET, manufactured by Solco Healthcare US LLC, is $0.0456 per EA (NDC 43547026850), effective Aug 19, 2026.
How has the price of ROPINIROLE HCL 0.25 MG TABLET changed over time?
Over the history we have for it, the NADAC for ROPINIROLE HCL 0.25 MG TABLET has declined 63.1%. It has been tracked across 659 weekly CMS publications since Jan 8, 2014.
What are the highest and lowest recorded NADAC prices for ROPINIROLE HCL 0.25 MG TABLET?
Since Jan 8, 2014, the NADAC for ROPINIROLE HCL 0.25 MG TABLET has ranged from a low of $0.0347 (Nov 20, 2024) to a high of $0.1260 (Mar 12, 2014), with a median of $0.0648 per EA.
Are there cheaper alternatives to ROPINIROLE HCL 0.25 MG TABLET?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ROPINIROLE HCL 0.25 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures ROPINIROLE HCL 0.25 MG TABLET?
ROPINIROLE HCL 0.25 MG TABLET (NDC 43547026850) is labeled by Solco Healthcare US LLC, and CMS classifies it as a generic product.